Detalhe da pesquisa
1.
Clofarabine monotherapy in aggressive, relapsed and refractory Langerhans cell histiocytosis.
Br J Haematol
; 204(5): 1888-1893, 2024 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-38501389
2.
Mixed Phenotype Acute Leukemia, B/Myeloid (Bilineal and Biphenotypic), With t(2;22)(q35;q12);EWSR1-FEV.
J Pediatr Hematol Oncol
; 43(3): e388-e394, 2021 04 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-32925408
3.
CNS Langerhans cell histiocytosis: Common hematopoietic origin for LCH-associated neurodegeneration and mass lesions.
Cancer
; 124(12): 2607-2620, 2018 06 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-29624648
4.
Overall survival of children and adolescents with mature B cell non-Hodgkin lymphoma who had refractory or relapsed disease during or after treatment with FAB/LMB 96: A report from the FAB/LMB 96 study group.
Br J Haematol
; 182(6): 859-869, 2018 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-29984828
5.
Comparative genomic expression signatures of signal transduction pathways and targets in paediatric Burkitt lymphoma: a Children's Oncology Group report.
Br J Haematol
; 177(4): 601-611, 2017 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-28474336
6.
Recent molecular and therapeutic advances in B-cell non-Hodgkin lymphoma in children.
Br J Haematol
; 173(4): 531-44, 2016 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-26996160
7.
Impact of persistent minimal residual disease post-consolidation therapy in children and adolescents with advanced Burkitt leukaemia: a Children's Oncology Group Pilot Study Report.
Br J Haematol
; 170(3): 367-71, 2015 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-25858645
8.
Outcome and pathologic classification of children and adolescents with mediastinal large B-cell lymphoma treated with FAB/LMB96 mature B-NHL therapy.
Blood
; 121(2): 278-85, 2013 Jan 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-23149845
9.
Rituximab with chemotherapy in children and adolescents with central nervous system and/or bone marrow-positive Burkitt lymphoma/leukaemia: a Children's Oncology Group Report.
Br J Haematol
; 167(3): 394-401, 2014 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-25066629
10.
Excellent outcomes in children and adolescents with CNS+ Burkitt lymphoma or other mature B-NHL using only intrathecal and systemic chemoimmunotherapy: results from FAB/LMB96 and COG ANHL01P1.
Br J Haematol
; 185(2): 374-377, 2019 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-30117142
11.
Rasburicase in the prevention of laboratory/clinical tumour lysis syndrome in children with advanced mature B-NHL: a Children's Oncology Group Report.
Br J Haematol
; 163(3): 365-72, 2013 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-24032600
12.
Rituximab pharmacokinetics in children and adolescents with de novo intermediate and advanced mature B-cell lymphoma/leukaemia: a Children's Oncology Group report.
Br J Haematol
; 162(5): 678-83, 2013 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-23802659
13.
Diagnosis and management of mature B-cell lymphomas in children, adolescents, and young adults.
Best Pract Res Clin Haematol
; 36(2): 101463, 2023 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-37353299
14.
Minimal disease assessment in the treatment of children and adolescents with intermediate-risk (Stage III/IV) B-cell non-Hodgkin lymphoma: a children's oncology group report.
Br J Haematol
; 153(6): 758-63, 2011 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-21496005
15.
Ibrutinib significantly inhibited Bruton's tyrosine kinase (BTK) phosphorylation,in-vitro proliferation and enhanced overall survival in a preclinical Burkitt lymphoma (BL) model.
Oncoimmunology
; 8(1): e1512455, 2019.
Artigo
em Inglês
| MEDLINE | ID: mdl-30546948
16.
A comparison of inpatient length of stay and costs among patients with hematologic malignancies (excluding hodgkin disease) associated with and without acute renal failure.
Clin Lymphoma Myeloma
; 8(1): 44-51, 2008 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-18501087
17.
Rasburicase: potential role in managing tumor lysis in patients with hematological malignancies.
Expert Rev Anticancer Ther
; 3(4): 429-33, 2003 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-12934655
18.
Advanced stage, increased lactate dehydrogenase, and primary site, but not adolescent age (≥ 15 years), are associated with an increased risk of treatment failure in children and adolescents with mature B-cell non-Hodgkin's lymphoma: results of the FAB LMB 96 study.
J Clin Oncol
; 30(4): 387-93, 2012 Feb 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-22215753
19.
Translocation (4;19)(q35;q13.1)-associated primitive round cell sarcoma: report of a case and review of the literature.
Pediatr Dev Pathol
; 11(3): 239-44, 2008.
Artigo
em Inglês
| MEDLINE | ID: mdl-17990934
20.
Phase I/II dose escalation study of recombinant human interleukin-11 following ifosfamide, carboplatin and etoposide in children, adolescents and young adults with solid tumours or lymphoma: a clinical, haematological and biological study.
Br J Haematol
; 128(1): 49-58, 2005 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-15606549